Cardiologs is a medical technology company committed to transforming cardiac diagnostics using medical-grade artificial intelligence and cloud technology.
CardioLogs® provides an innovative software technology enabling any healthcare professional to accurately and reliably screen patients for cardiovascular diseases.
Cardiologs was founded in 2014 by Yann Fleureau and Jia Li. The company is headquartered in Paris, France, with an office in Boston, Massachusetts.
CardioLogs® leverages cutting-edge machine learning technology and medical expertise to deliver top ECG interpretation services.
Cardiologs' ability to quickly detect and diagnose heart conditions as effectively as the world's top human cardiologists has promising implications. The AI model, which was trained on more than 1.4 million ECG recordings, is capable of spotting more than 100 different cardiac abnormalities and is FDA- cleared for all clinically-relevant arrhythmias.
Cardiologs is partnering with clinicians and healthcare practitioners across four continents to realize the vision of making expert cardiac diagnostics scalable and accessible to everyone.
Cardiologs is backed by Idinvest Partners, Alven, Bpifrance, ISAI, Kurma Diagnostics and others. The company raised $15M in a Series A financing on Jan 10, 2020. This new round brings Cardiologs' total funding to over $25M to date.